Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Wenzhou, China.
Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Front Public Health. 2021 Aug 20;9:670889. doi: 10.3389/fpubh.2021.670889. eCollection 2021.
COVID-19, the coronavirus disease 2019; SARS-CoV-2, the coronavirus 2; ACE2, angiotensin converting enzyme 2; S protein, spiked glycoprotein; TMPRSS2, transmembrane serine protease 2; WHO, World Health Organization. Although the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2, has been viably controlled in China, a new normal in healthcare strategies has become standard in China and worldwide. We conducted a questionnaire study to disseminate the experience from China in terms of urology outpatient prevention and control measures under standardized prevention policies against COVID-19. From May 3, 2020 to June 25, 2020, we conducted an anonymous cross-sectional questionnaire study, focused on the status of and experiences with outpatient urology prevention and control measures during the COVID-19 pandemic. The targeted respondents were urologists in mainland China, covering all levels of hospitals and clinics. A total of 216 (97%) valid responses were collected. We found that 183 (85%) respondents were from outside of Hubei province in China. One-hundred-and-fifty-eight (73%) respondents believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. Over 80% of respondents recommended WeChat application or similar online video meetings for virtual outpatient consultations. The suggested flowcharts and recommendations to prevent new cases were easy to understand and approved by most physicians, which could provide reference for outpatient prevention and control. We still need to make adequate preparations under the new normal of the COVID-19 Epidemic, especially for those suspected of being infected. Although the scientific validation of the questionnaire is limited, it provides a first snapshot of the experiences relating to the prevention and control measures in urology clinics in China, and can inform future policies in this field.
新型冠状病毒肺炎（COVID-19），即 2019 年冠状病毒病；严重急性呼吸综合征冠状病毒 2（SARS-CoV-2），即 2019 年新型冠状病毒；血管紧张素转换酶 2（ACE2）；刺突糖蛋白（S 蛋白）；跨膜丝氨酸蛋白酶 2（TMPRSS2）；世界卫生组织（WHO）。虽然由严重急性呼吸综合征冠状病毒 2 引起的新型冠状病毒肺炎（COVID-19）大流行在中国已得到有效控制，但在卫生保健策略方面的新常态已成为中国乃至全球的标准。我们进行了一项问卷调查研究，旨在传播中国在根据针对 COVID-19 的标准化预防政策下，泌尿外科门诊防控措施方面的经验。
自 2020 年 5 月 3 日至 2020 年 6 月 25 日，我们进行了一项匿名的横断面问卷调查研究，重点是 COVID-19 大流行期间泌尿外科门诊防控措施的现状和经验。目标受访者为中国大陆的泌尿科医师，涵盖各级医院和诊所。共收集到 216 份（97%）有效回复。我们发现，183 名（85%）受访者来自中国湖北省以外的地区。158 名（73%）受访者认为可以在尿液中检测到 SARS-CoV-2，需要对尿液暴露进行防护。超过 80%的受访者建议使用微信应用程序或类似的在线视频会议进行虚拟门诊咨询。建议的防止新发病例的流程图和建议易于理解，并得到大多数医生的认可，可为门诊防控提供参考。我们仍需要在 COVID-19 大流行的新常态下做好充分准备，尤其是对疑似感染者。
虽然问卷调查的科学验证受到限制，但它提供了中国泌尿外科诊所防控措施经验的第一手资料，可以为该领域的未来政策提供信息。
